Table 1. Predicted antiviral activities (% inhibition) of cytidine derivatives 2–15, remdesivir, and AZT.

Compounds	General	HBV	HCV	HHV	HIV
1	-	-	-	-	-
2	56.694	24.616	52.294	39.139	60.776
3	50.334	25.168	44.745	68.231	69.760
4	51.770	25.164	44.746	65.844	70.174
5	7.689	20.217	18.367	48.010	71.148
6	5.209	22.034	17.707	32.962	62.485
7	8.964	19.478	38.064	46.137	65.673
8	54.817	25.306	58.732	51.525	55.146
9	2.101	19.505	44.539	44.016	68.671
10	2.327	19.694	37.089	45.767	68.719
11	50.134	24.790	47.106	60.254	62.961
12	4.310	20.681	37.091	43.999	69.047
13	3.345	19.376	56.274	81.466	65.758
14	47.021	26.981	46.291	75.321	63.214
15	61.039	18.367	53.816	61.409	63.427
Remdesivir	48.642	22.443	66.968	36.291	69.503
AZT	87.038	19.619	24.962	28.728	92.855

HBV = Hepatitis B virus; HCV = Hepatitis C virus; HHV = Human herpesvirus; HIV = Human immunodeficiency virus.